Article Information
History
- March 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Andrew Y.F. Li Yim1,2,
- Nicolette W. Duijvis3,4,
- Mohammed Ghiboub2,3,
- Catriona Sharp2,
- Enrico Ferrero2,#,
- Marcel M.A.M. Mannens1,
- Geert R. D’Haens4,
- Wouter J. de Jonge3,5,
- Anje A. te Velde3,* and
- Peter Henneman1,*
- 1Amsterdam University Medical Centers, University of Amsterdam, Genome Diagnostics Laboratory, Department of Clinical Genetics, Amsterdam Reproduction & Development, Amsterdam, the Netherlands
- 2R&D GlaxoSmithKline, Stevenage, United Kingdom
- 3Amsterdam University Medical Centers, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology & Metabolism, Amsterdam, the Netherlands
- 4Amsterdam University Medical Centers, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology & Metabolism, Amsterdam, the Netherlands
- 5University Clinic of Bonn, Department of Surgery, Bonn, Germany
- ↵*Correspondence: Peter Henneman (p.henneman{at}amsterdamumc.nl; +31-(0)20-5664965) and Anje te Velde (a.a.tevelde{at}amsterdamumc.nl; +31-(0)20-5668153)
Posted March 12, 2020.
Whole-genome DNA methylation profiling of CD14+ monocytes reveals disease status and activity differences in Crohn’s disease patients
